Enhancing clinical trial diversity: Improving awareness, access, and trust

Sponsored by Deloitte Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those affected by the disease or condition being investigated. Join this panel discussion on how the biopharma industry can enhance clinical trial diversity. We’ll discuss opportunities to:

Related Articles